RxDoctor Payments Data

Vidhya Chandramohan, MD

Hospitalist · Winston Salem, NCNPI 1356661631

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 349 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,236 and has fallen 50.4% since, to $613 in 2025. Among hospitalist clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,059in general payments, 2019–2025

Across 349 payments — averaging $17.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$1K
  • AbbVie$786
  • Novartis$743
  • Merck$576
  • Boehringer Ingelheim$575
  • AstraZeneca$439
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$6,059100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,059 in reported general payments places this provider in the 90th percentile of 879 hospitalist providers in North Carolina.

See all hospitalist providers in North Carolina

Medicare billing

Part B allowed, 2024
$53,765
Medicare patients
183
Services billed
584

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip15$250
Ondansetron Hcl21$117
Pantoprazole Sodium22$107
Prednisone20$83
Amlodipine Besylate11$80
Oxycodone Hcl13$45
Furosemide11$37

Paid to pharmacies, not to this prescriber.

Other hospitalist in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →